GLYC

GlycoMimetics, Inc. Press Releases

$8.32
*  
0.09
1.09%
Get GLYC Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading GLYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
GlycoMimetics to Present at Two Investor Conferences in March
2/26/2015 9:00:00 AM - Business Wire


GlycoMimetics to Present at 17th Annual BIO CEO & Investor Conference
2/3/2015 9:00:00 AM - Business Wire


GlycoMimetics Highlights Potential Therapeutic Benefits of Its Novel E-Selectin Antagonist at 56th ASH Annual Meeting
12/9/2014 9:00:00 AM - Business Wire


University of Michigan to Study GlycoMimetics’ GMI-1271 as Potential Treatment for Serious Blood-Clotting Disorder
12/4/2014 9:00:00 AM - Business Wire
▼-8.07 % Price Change since this news event. The Volume Ratio is 2.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day